Two approaches were used to demonstrate that reduction in serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in children with sickle cell disease is related to a deficiency of antibodies to pneumococcal capsular polysaccharide. First, opsonization of S. pneumoniae mediated by the alternative pathway in patients' sera was restored to normal by addition of the purified IgG or IgM fraction of goat antiserum to capsular polysaccharide of the homologous serotype. Secondly, IgG antibody titers to capsular polysaccharide in patients' sera correlated significantly with alternative pathwaymediated opsonization; the correlation between titers of IgM anticapsular antibodies and opsonization approached statistical significance. The sum of the IgG and IgM anticapsular antibody titers correlated most significantly with opsonization. Our results suggest that reduction in alternative pathway-mediated opsonization in sera from children with sickle cell disease is related to low levels of both IgG and IgM anticapsular antibodies.
Introduction
Children with sickle cell disease are at high risk of development of pneumococcal septicemia and meningitis (1) (2) (3) . Splenic hypofunction is a major factor contributing to the increased susceptibility to pneumococcal infection (4) (5) (6) . A second, less well characterized alteration of host defense occurring in a subpopulation ofchildren and adults with sickle cell disease is reduction in serum opsonization ofStreptococcus pneumoniae (7) (8) (9) (10) (11) (12) (13) (14) . Initial studies attempting to characterize this alteration examined the relationship between serum opsonization of S. pneumoniae and various functional measurements ofcomplement, i.e., total hemolytic complement and C3 conversion by activators of the alternative complement pathway (zymosan, inulin, and cobra venon factor) (7) (8) (9) (10) . Total hemolytic complement was found to be below normal in certain sera, but not consistently in opsonically deficient sera (7) (8) (9) (10) . Johnston et al. demonstrated that C3 conversion by zymosan was reduced in these sera (8) . How-1986 . ever, studies from our laboratory using inulin and cobra venom factor as the complement activators demonstrated normal C3 conversion in opsonically deficient sera (9, 10) .
Subsequent studies from our laboratory have attempted to resolve the divergent results. Opsonization of S. pneumoniae selectively mediated by the alternative and classical pathways and concomitant deposition of C3 fragments on the bacterial surface were measured in sera from children with sickle cell disease and normal siblings of similar age (14) . Both alternative and classical pathway-mediated opsonization were found to be significantly reduced in a subset of children with sickle cell disease. Reduction in classical pathway-mediated opsonization was related to a quantitative decrease in C3 deposition on the pneumococci; however, total hemolytic complement reflecting the intrinsic functional activity ofthe classical pathway was normal in the sera. Reduction in alternative pathway-mediated opsonization was associated with normal C3 deposition. These observations suggested that opsonization might be reduced by a deficiency ofauxiliary serum factors required for classical pathway activation, such as antibodies. An antibody deficiency might also explain the reduction in alternative pathway-mediated opsonization, since antibodies although not required for alternative pathway activation act synergistically with surface-bound C3 fragments to enhance phagocytosis (15, 16) . The findings of Johnston et al. (8) might also be related to an antibody deficiency, since opsonization was normalized in their study when the pneumococci were presensitized with a high concentration of antipneumococcal antibodies before incubation with patient's serum and it is now recognized that C3 conversion by zymosan and other alternative pathway activators is influenced by antibodies ( 17) . Additional support for the concept that antibodies may play a role in the reduction in opsonization in sickle cell disease has been derived from a preliminary study from our laboratory demonstrating restoration of opsonic activity in patients' sera by IgG fractionated from normal human serum (18) .
The present investigation extends the observations described above by providing direct evidence that reduction in serum opsonization via the alternative complement pathway in children with sickle cell disease is related to a deficiency of antibodies to pneumococcal capsular polysaccharide. Two experimental approaches were used. First, the ability of purified IgG and IgM fractions of goat antiserum to pneumococcal capsular polysaccharide to restore alternative pathway-mediated opsonization of the homologous pneumococcal serotype in patients' sera was determined. Secondly, IgG and IgM antibody titers to the capsular polysaccharide were compared in sera from patients and controls, and correlations between these titers and alternative pathway-mediated opsonization in patients' sera were assessed.
A preliminary investigation of the mode of enhancement of alternative pathway-mediated opsonization by anticapsular IgG and IgM was also undertaken. were run simultaneously. Gels were fixed overnight in an aqueous solution of 25% propanol and 10% glacial acetic acid. Gels were silver stained using reagents from Bio-Rad Laboratories (Richmond, CA) and the manufacturer's directions. Double immunodiffusion. Double immunodiffusion was carried out at room temperature for 18 h in 0.6% agarose in PBS, pH 7.0. Antisera to goat IgM (gamma chain-specific), goat IgG (Fc-specific), and whole goat serum (Pel-Freez Biologicals) were used.
Growth ofthe bacteria. Serotype 1OA S. pneumoniae was a clinical isolate used in our previous studies (9, 10, 14, 18 Rg/ml ofcytochalasin B to inhibit ingestion before mixture with opsonized bacteria (30). Measurements of bacterial uptake and killing were performed as previously described (14) . For measurement ofbacterial uptake, aliquots were centrifuged at 190 gfor 5 min at 4VC. The leukocytes were washed three times with cold HBG. Leukocyte pellets and samples removed before incubation for measurement of input counts per minute were solubilized and counted. For measurement of killing, aliquots removed before and after incubation were serially diluted in distilled water and plated on blood agar. Percent uptake, reflecting both adherent and ingested bacteria, was calculated by dividing the counts per minute in the leukocyte pellets by the input counts per minute and multiplying by 100. Percent killing was calculated by the formula (a -b)/a X 100, where a and b were equal to surviving cfu/ml before and after incubation, respectively. The 8-min incubation time was used, because it was the minimum required for maximal uptake and killing ofbacteria opsonized with normal sera. In some experiments, purified immunoglobulin preparations were added together with the leukocytes after opsonization of the bacteria with serum.
Adsorption ofanticapsular IgG and IgM with bacteria. Purified IgG and IgM fractions of goat antiserum to capsular polysaccharide (I mg/ ml) were adsorbed for 30 min at 370C with 20% packed volume of serotype 10A S. pneumoniae or S. pneumoniae R36a. After adsorption, bacteria were pelleted by centrifugation, and the supernatants were removed.
Electron microscopy. Bacteria were incubated with serum and anticapsular IgG or serum alone using the conditions described for opsonization, except the bacteria were not radiolabeled. After washing, the bacteria were incubated with polymorphonuclear leukocytes under the conditions used for measurement of bacterial uptake. The leukocytes were washed three times with HBG, fixed in 2.5% glutaraldehyde in 0.07 M sodium cacodylate buffer for 4 h at 4VC, and dehydrated in graded alcohol solutions and propylene oxide. The samples were embedded in Spurr medium, thin-sectioned with an ultramicrotome, and stained with uranyl acetate and lead citrate. The preparations were examined and photographed using a Zeiss 9S electron microscope (Carl Zeiss, Inc., Thornwood, NY). These studies were performed by Dr (31) showed that hemolytic activity in radioiodinated C3 was equivalent to that in nonlabeled C3 on a weight basis, indicating that no loss of functional activity resulted from the iodination procedure. Radioiodinated and nonlabeled anticapsular IgG and IgM also had similar functional activity as assessed by comparing the ability of these preparations to restore opsonization in patients' sera.
Quantitation of C3 deposition. C3 deposition on serotype 10A * pneumoniae was measured by radioassay as described previously (14) . Briefly, serum was supplemented with radioiodinated C3, centrifuged to remove possible aggregates, and incubated with the bacteria and purified immunoglobulin preparations under the conditions used for opsonization. Controls contained 0.01 M EDTA to inhibit complement activation. After incubation for 15 min at 37°C, samples were removed for measurement of bacterial-bound and total radioactivity. Measurement of binding of anticapsular IgG and IgM to bacteria. Serotype 1OA S. pneumoniae or S. pneumoniae R36a (5.0 X 106 cfu) were incubated for 15 min at 370C with purified radioiodinated anticapsular IgG or IgM (3.25-30 Mtg) in a total volume of 100 ,l. Reaction mixtures were prepared in duplicate. After incubation, 75-Ml samples were centrifuged through 300 ,l of 20% sucrose, and bacterial-bound and total radioactivity were measured. Results were expressed as immunoglobulin molecules bound per cfu and were calculated by the formula [(Mg bound immunoglobulin X 10-6)/150,000 (IgG) or 900,000 (IgM) X (6.023 X 1023)]/3.75 X 106.
Measurement of antibody titers to pneumococcal capsular polysaccharide. Total IgG and IgM antibody titers to serotype lOA capsular polysaccharide were measured by the enzyme-linked immunosorbent assay (ELISA) using a minor modification of the method of Barrett et al. (32) . Purified serotype 1OA capsular polysaccharide obtained from the American Type Culture Collection was coupled to poly-L-lysine by the method of Gray (33) . After coupling, the polysaccharide was dialyzed overnight at 4VC against PBS, pH 7.4, and stored at 4VC. For coating wells, 100 Ml of polysaccharide diluted to 8 Mg/ml in 0.25 M sodium bicarbonate/carbonate buffer, pH 9.5, was added to the inner wells of microtiter plates (NUNC Immuno-1; Gibco Laboratories, Grand Island, NY), and the plates were incubated overnight at 4°C. Unbound polysaccharide was removed by three washes with distilled water followed by a 10-min soak in 0.15 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 0.05% Tween 20 (PBS-Tween). Twofold dilutions (1:5-1: 2560) of the test sera and reference serum from an adult donor were prepared in PBS-Tween, and 100,Ml was added in duplicate to the wells.
Control wells to which no serum was added were included in quadruplicate on each plate. The plates were incubated for 2 h at room temperature and then washed extensively as described above. (anti-IgG4). After washing the plates three times with PBS-tween, 100
Ml of a 1:500 dilution of alkaline phosphatase conjugated anti-mouse IgG (Sigma Chemical Co.) in PBS-Tween was added to the wells, and the plates were incubated for 2 h at room temperature. After additional washing, substrate was added, and the reactions were stopped after 15 min ofincubation at room temperature. Absorbance was read, and titers were calculated as described above. Controls without antigen or monoclonal antibody were included in all experiments. Absorbance readings in these controls were negligible.
The specificity and sensitivity of the assays were determined using reference preparations of human IgG subclass proteins obtained from the World Health Organization, Berne, Switzerland. Two preparations of each subclass, one each with lambda and kappa light chains, were used. For determinations ofspecificity, wells were coated at 4VC overnight with 100 ;d of the IgG subclass proteins (1 jig/ml) in 0.25 M sodium bicarbonate/carbonate buffer, pH 9.5. After washing the plates three times with PBS-Tween, monoclonal antibodies in dilutions used in the experiments described above were added to the wells and incubated for 2 h at room temperature. The rest of the procedure was carried out as described above. For determination of the sensitivity of the assays, wells were coated with fivefold dilutions of the IgG subclass proteins at concentrations ranging from 1 to 0.01 Jg/ml. Monoclonal antibody to the homologous subclass at the dilution used above was then added followed by anti-mouse IgG.
Statistical analysis. Differences between antibody titers were determined by the Wilcoxon rank sum test (34). Correlations were assessed by Spearman rank-order correlation (34).
Results
Purity ofanticapsular IgG and IgM. The IgG and IgM fractions of antiserum to pneumococcal capsular polysaccharide used in our experiments were highly purified as assessed by SDS polyacrylamide gel electrophoresis (Fig. 1) . The immunoglobulin preparations formed a single precipitin line in double immunodiffusion with antiserum to whole goat serum and reacted strongly with antiserum to the homologous heavy chain of goat immunoglobulin. Reactivity was not demonstrated with antiserum to the heterologous heavy chain, indicating that the IgG and IgM preparations were devoid of cross contamination.
Requirement for complement for opsonization. Preliminary experiments demonstrated that treatment of normal human serum with 0.01 M EDTA or by heating for 30 min at 560C ablated uptake and killing of the pneumococcal test organism (serotype lOA) by polymorphonuclear leukocytes, indicating that complement was essential for opsonization. Total hemolytic complement was undetectable in serum treated with MgEGTA, indicating that the chelation conditions used during opsonization effectively blocked the classical complement pathway.
Enhancement ofalternative pathway-mediated opsonization by anticapsular IgG and IgM. 10 patients with hemoglobin SS ranging in age from 2 to 18 yr were used in this part of our investigation. Sera from these patients had been previously shown to have reduced alternative pathway-mediated opsonic activity for serotype 1OA S. pneumoniae as compared with controls of similar age (14) . Reduction in opsonic activity was manifest by bacterial uptake by normal polymorphonuclear leukocytes in the low normal or abnormal range and markedly reduced killing by the leukocytes. Supplementation ofpatients' sera with purified anticapsular IgG or IgM restored bacterial uptake and killing to normal or supranormal levels. Representative results obtained with sera from four patients are shown in Fig. 2 . The trend of results was similar using sera from the other six patients. Using these sera without added immunoglobulin, uptake and killing (mean±l SD) were 58±10% and 17±17%, respectively. Addition of 50 ,g of anticapsular IgG to these sera increased uptake and killing to 81±12% and 86±2%, respectively; anticapsular IgM at the same concentration increased uptake and killing to 82±17% and 72±13%, respectively. The effect of the immunoglobulin preparations on the opsonic activity of a pool of normal serum was also determined. Uptake and killing (mean± 1 take was not further increased. Anticapsular IgG and IgM (12.5-50 gg) promoted < 15% uptake and killing in the absence of serum. These results indicated that the immunoglobulin preparations enhanced opsonization in both patients' and normal sera by acting synergistically with complement. Experiments were performed to determine why patients' sera were capable of facilitating bacterial uptake by polyrmorphonuclear leukocytes but minimal killing in the absence of added immunoglobulin. Leukocytes were treated with cytochalasin B under conditions known to inhibit ingestion, and uptake ofbacteria opsonized with patients' sera and pooled normal human serum was compared. Uptake ofbacteria opsonized with patients' sera was unaffected by treatment of the leukocytes with cytochalasin B (data not shown), whereas the cytochalasin B treatment reduced uptake of bacteria opsonized with normal serum from 85% to 52%. These results suggested that patients' sera facilitated adherence of the pneumococci to polymorphonuclear leukocytes but were unable to promote the internalization phase of phagocytosis necessary for killing. Additional support for this concept was derived from electron microscopic studies. In these studies, bacteria were opsonized with patient's serum in the presence or absence of 50 jsg of anticapsular IgG. The opsonized bacteria were incubated with normal polymorphonuclear leukocytes, and nonleukocyte-associated bacteria were removed using the conditions employed in the uptake assay. When the bacteria were opsonized with patient's serum in the absence of IgG, few polymorphonuclear leukocytes contained ingested bacteria. When present, ingested bacteria occurred singly within phagocytic vacuoles (Fig. 3) . In contrast, when the bacteria were opsonized with patient's serum in the presence of IgG, most polymorphonuclear leukocytes contained ingested bacteria, and two or more bacteria were routinely observed within phagocytic vacuoles in various stages of disintegration. These data visually documented the positive effect of anticapsular IgG on ingestion of the pneumococci.
Effect ofanticapsular IgG and IgM during and after opsonization. To investigate the mode of enhancement of opsonization by anticapsular IgG and IgM, these preparations were added during opsonization of the'bacteria with patients' sera or afterwards together with the polymorphonuclear leukocytes. The same amount of IgG or IgM was added under both sets of conditions. Addition of the immunoglobulin preparations during opsonization resulted in a marked enhancement ofbacterial uptake and killing (Table I ). In contrast, these preparations had no effect on uptake and killing if added after opsonization. These results indicated that both anticapsular IgG and IgM enhanced opsonization through a direct interaction with complement.
Effect of anticapsular IgG and IgM on C3 deposition. To (14) , normal numbers of C3 molecules were deposited on the pneumococci in the absence of added immunoglobulin, indicating that alternative pathway-mediated C3 deposition under these conditions occurred normally (Fig. 4) IgG and IgM) markedly enhanced opsonization and C3 deposition in patients' sera, whereas heat-inactivated normal goat serum had less ofan effect on these parameters. Secondly, binding studies with radioiodinated anticapsular IgG and IgM confirmed that these preparations contained antibodies reactive with serotype lOA (Fig. 5) . Anticapsular IgG and IgM bound minimally to S. pneumoniae R36a, an unencapsulated strain, suggesting that the majority ofantibodies in these preparations were directed against the capsular polysaccharide. Thirdly, adsorption of anticapsular IgG and IgM with serotype lOA S. pneumoniae rendered these preparations inactive with respect to restoring opsonization in patient's serum, whereas adsorption with S. pneumoniae R36a had no effect on restoration ofopsonization. The results obtained with anticapsular IgG are shown in Fig. 6 ; results with anticapsular IgM were similar (data not shown). Relationship between serum antibody titers to capsularpolysaccharide and alternative pathway-mediated opsonization.
Twenty nine patients with sickle cell disease and 14 normal controls were used in this part of our investigation. The patients were subdivided into a group of 13 with reduced alternative pathway-mediated opsonic activity for serotype lOA and a group of 16 with normal opsonic activity for this serotype (Table II) . The first group included seven ofthe patients studied in the first part of our investigation. Subjects in the three groups were of similar age.
Serum IgG and IgM antibody titers to capsular polysaccharide in the two patient groups and controls were first compared. IgG anticapsular antibody titers were significantly reduced in sera from the first patient group (opsonically deficient) as compared with the second patient group (opsonically normal) and controls (P < 0.001, Table II ). Serum IgM anticapsular antibody titers were not significantly different in the three groups.
Correlations were assessed between IgG and IgM antibody titers to capsular polysaccharide and alternative pathway-mediated opsonic activity in patients' sera. IgG anticapsular antibody titers correlated significantly with measurements ofuptake and killing (P < 0.005, Fig. 7 A) . Correlations between IgM anticapsular antibody titers and these measurements approached statistical significance (P > 0.05 < 0.1, Fig. 7 B) . The most significant correlations were between the sum of the IgG and IgM antibody titers and uptake and killing (P < 0.001, Fig. 7 C) . These results indicated that reduction in alternative pathwaymediated opsonization in the patients' sera was related to low levels of both IgG and IgM anticapsular antibodies. IgG subclass-specfic antibody titers to serotype lOA capsular polysaccharide were also measured in sera from a subset of 20 children with sickle cell disease. 19 of these patients were the same as those analyzed in the preceding experiments. Normal controls were not included in this part of our study, because the quantities of sera on these subjects were insufficient to perform the analyses. Preliminary experiments confirmed the specificity of the monoclonal antibodies to IgG subclasses used in the IgG subclass-specific ELISAs. The lower limit of detection in these assays was 0.01 gg/ml of IgGl and IgG3, 0.1 ,ug/ml of IgG2, and 0.05 gg/ml of IgG4. Patients were again subdivided into two groups according to opsonic activity (Table III) (17) . In these latter studies, a major effect of IgG was to increase C3 deposition via the alternative pathway on the test activators.
Minimal information is available concerning interactions between antibodies of the IgM class and the alternative complement pathway. Okada et al. (40) reported that natural IgM antibodies participated in alternative pathway-mediated lysis of liposomes containing paragloboside in their membranes. IgM has been shown to bind C3b to a greater extent than IgG (41), and a recent study suggests that anti-pneumococcal antibodies of both the IgG and IgM classes bind C3b covalently (42). Through their interaction with C3b, antibodies to the pneumococcal capsular polysaccharide may redirect alternative pathway activation and further C3b deposition from the area of the bacterial cell wall to the capsule and thereby enhance bacterial phagocytosis (43, 44) .
In our study, anticapsular IgG and IgM appeared to primarily affect the internalization phase of phagocytosis. Experiments in which phagocytosis was inhibited by treatment of polymorphonuclear leukocytes with cytochalasin B suggested that patients' sera facilitated adherence but not ingestion and killing of the pneumococci in the absence ofadded immunoglobulin. Addition of anticapsular IgG or IgM to patients' sera increased bacterial uptake and killing by the leukocytes. Since adherence was near normal or in the low normal range in the absence of added immunoglobulin, the major effect of anticapsular IgG and IgM appeared to be in triggering phagocytosis, which was necessary for killing. Further support for this concept was derived from electron microscopic studies comparing ingestion of bacteria opsonized with patient's serum with and without added anticapsular IgG. Anticapsular IgG and IgM may also directly affect the intracellular killing process, although this was not established in our study.
Synergism between antibodies and complement in the in- The relative contributions ofantibodies and C3b to bacterial phagocytosis are not well understood, because there have been few studies in which purified proteins have been used. C3b on certain bacterial strains appears to be capable of promoting phagocytosis in the absence of antibodies, whereas phagocytosis of other strains appears to be dependent on both antibodies and complement (50) (51) (52) . Both IgG and IgM antibacterial antibodies have been shown to act synergistically with complement in the induction of phagocytosis, although the mechanisms involved have not been explored (50) . These observations and those of our investigation suggest that IgM antibodies like those of the IgG class play an important role in the induction of bacterial phagocytosis by polymorphonuclear leukocytes, and both classes of antibodies exert their effect without involvement of the Fc receptor.
Relationships between serum opsonization ofS. pneumoniae and titers of IgG and IgM anticapsular antibodies in children with sickle cell disease have not been previously investigated. Class-specific antibody responses to the pneumococcal polysaccharide vaccine have been compared in children with sickle cell disease and normal children of similar age (53) . The level and predominant class of antibody were shown to vary with the serotype of antigen tested. Although statistically significant differences were not found, lower responses were noted in the children with sickle cell disease than in the controls. Serum opsonic activity was not measured in this study. Chudwin et al. (54) have recently investigated the relationship between serum opsonic activity for serotype 7F S. pneumoniae and total antibodies to serotype 7F capsular polysaccharide measured by radioimmunoassay in children with sickle cell disease following immunization with pneumococcal polysaccharide vaccine. A significant correlation between these measurements was observed, and patients were identified whose opsonic and total antibody responses to vaccination were poor. It is probable that these patients represent a subset similar to those identified in our study who respond poorly to natural exposure to S. pneumoniae.
Mechanisms underlying the depression in humoral immunity to pneumococcal capsular polysaccharide in certain children with sickle cell disease are currently unknown. Splenic hypofunction may contribute to the altered state of immunity, since a similar condition, splenectomy, has been associated with depressed immune responses to pneumococcal polysaccharide vaccine (19, (55) (56) (57) (58) and diminished secretion of immunoglobulins by peripheral blood mononuclear cells in response to stimulation with pokeweed mitogen (59) (60) (61) (62) (63) . The role of genotypic variation in patients with sickle cell disease also requires exploration in light of a recent report demonstrating a relationship between immunoglobulin allotypes and the immune response to pneumococcal capsular polysaccharides in normal subjects (64).
